BCLI

BRAINSTORM CELL THERAPUTC
BCLI

Overview Fund Activity
Delisted

BCLI was delisted on the 17th of July, 2025.

Back to rankings

28 hedge funds and large institutions have $4.35M invested in BRAINSTORM CELL THERAPUTC in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
+5
Holders Change %
+21.74%
% of All Funds
0.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
6
Reduced
4
Closed
2
Calls
$47K
Puts
–
Net Calls
+$47K
Net Calls Change
+$47K

Top Buyers

1
PA
1
Perceptive Advisors
New York
$1.07M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.3M
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$50K
4
PVH
4
Psagot Value Holdings
Israel
$61K
5
Citadel Advisors
5
Citadel Advisors
Florida
$32K

Top Sellers

1
SM
1
Sabby Management
Florida
$1.32M
2
ARTA
2
A.R.T. Advisors
New York
$60K
3
Group One Trading
3
Group One Trading
Illinois
$0
4
BFA
4
BlackRock Fund Advisors
California
$114K
5
UBS Group
5
UBS Group
Switzerland
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
DOA
26
D'Orazio & Associates
Virginia
$1K +$1K +33 New
Geode Capital Management
27
Geode Capital Management
Massachusetts
$163 – – –
PCM
28
Penserra Capital Management
California
$13 +$4 +111 +50%
Group One Trading
29
Group One Trading
Illinois
– -$11K -259 Closed
UBS Group
30
UBS Group
Switzerland
– -$3K -68 Closed
1
2